Clene Inc. (NASDAQ:CLNN) Receives Average Rating of "Buy" fr

Clene Inc. (NASDAQ:CLNN) Receives Average Rating of "Buy" from Brokerages

Clene Inc. (NASDAQ:CLNN – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their coverage on the stock in the […]

Related Keywords

United States , America , Davidj Matlin , , America Corp , Charles Schwab Investment Management Inc , Goldman Sachs Group Inc , Clene Inc , Nasdaq , Jpmorgan Chase Co , Get Free Report , Director David , Schwab Investment Management , Street Corp , Sachs Group , Get Free , Multiple Sclerosis , Clene Daily , Clene , Nasdaq Clnn , Clnn , Medical , Ratings , Consensus ,

© 2025 Vimarsana